Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05543512 · ClinicalTrials.gov registry record · NA

The Immune Directed Individualized Elimination Therapy (iDIET) Study

A NA study of Eosinophilic Esophagitis and EoE, sponsored by University of North Carolina, Chapel Hill.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05543512 is a NA study of Eosinophilic Esophagitis and EoE that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants, below the 862-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05543512, a NA study of Eosinophilic Esophagitis and EoE, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, double blind, sham-controlled, pilot/feasibility trial of individualized dietary elimination treatment.

Interventions

  • DEVICE Algorithm to diagnose food allergens
  • OTHER Sham diet

Study Locations (1)

North Carolina

  • The University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-10-14
Est. Completion 2026-03
Phase NA

What the Registry Record Tells You About NCT05543512

The ClinicalTrials.gov registry entry for NCT05543512 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 862-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (88% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 2 interventions - of which Algorithm to diagnose food allergens is the first listed.

NCT05543512 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05543512 about?

NCT05543512 is a clinical study titled "The Immune Directed Individualized Elimination Therapy (iDIET) Study". This is a randomized, double blind, sham-controlled, pilot/feasibility trial of individualized dietary elimination treatment.

What is the current status of trial NCT05543512?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-10-14. Estimated completion is 2026-03.

What conditions does trial NCT05543512 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis, EoE.

What interventions are being tested in trial NCT05543512?

The interventions under investigation include: Algorithm to diagnose food allergens (DEVICE), Sham diet (OTHER).

Who is sponsoring clinical trial NCT05543512?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05543512 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.